ArticlePediatric research2025
Development and validation of a prediction model for bronchopulmonary dysplasia using respiratory severity score.
Article in Pediatric research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Factors associated with short-term response after systemic corticosteroid treatment in invasively ventilated preterm infants.BMC pediatrics · 2026Article
- Threshold Effect of Cumulative Postnatal Corticosteroid Dose on Long-Term Outcomes in Extremely Preterm Infants.Journal of clinical medicine · 2026Article
- Toward precision for bronchopulmonary dysplasia: Moving past current definitions.Journal of perinatology : official journal of the California Perinatal Association · 2026Review
- Respiratory severity score-guided postnatal systemic corticosteroid therapy for bronchopulmonary dysplasia in extremely preterm infants.Clinical and experimental pediatrics · 2025Article
- Can we really predict the respiratory morbidity of preterm birth?Pediatric research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo develop and validate a prediction model for severe bronchopulmonary dysplasia (BPD) that integrates the respiratory severity (RS) score with early postnatal risk factors.
methodsThis retrospective cohort study included preterm infants born at less than 32 weeks gestation or with a birth weight of less than 1500 g, from Aichi Prefecture (training dataset) and Saitama Medical University (validation dataset) from April 1, 2016, to March 31, 2020. The primary outcome was severe BPD, defined as the use of home oxygen therapy or death due to BPD. We used classification and regression tree (CART) analysis to explore the relationship between outcomes and BPD risk factors in the training dataset.
resultsThe incidence of severe BPD was 149 out of 2026 (7.3%) in the training dataset and 35 out of 387 (8.9%) in the validation dataset. CART analysis identified gestational age and the RS score as significant predictors of outcome in the day 7 and day 14 models, with C-statistics of 0.789 and 0.779, respectively. When applied to the validation dataset, these models achieved C-statistics of 0.753 and 0.827, respectively.
conclusionOur prediction models demonstrated the ability to predict severe BPD, with the RS score being a crucial predictor. IMPACT: Many existing prediction models for bronchopulmonary dysplasia (BPD) use multiple predictors, and do not provide specific cutoff values, which complicates their clinical application. To address this issue, we developed a prediction model for severe BPD based on a score derived from mean airway pressure and inhaled oxygen concentration at 1-2 weeks of age. This user-friendly model can be easily integrated into clinical practice, facilitating treatment decisions based on predicted probabilities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.